DocGo to Provide Digital Transportation Management Platform, Dedicated Ambulance Service to Major New York Health System
Through this contract, DocGo's dispatchers located within the health system's discharge management office will use DocGo's proprietary transportation management software for centralized management of all discharges across the health system. Through its Ambulnz brand, DocGo will also provide dedicated basic life support (BLS) ambulance services at select facilities.
'The consolidated, centralized transportation data offered by DocGo's software platform is the foundation for quality improvement initiatives on patient throughput, transportation timeliness and other key metrics,' said DocGo CEO Lee Bienstock. 'We've been working on this partnership for months, and we are gratified to see DocGo's technology suite and medical transportation services helping enhance patient flow and drive satisfaction through timely transport and greater visibility into exactly when transportation will arrive.'
Transportation services commenced in July and will ramp up over the balance of the quarter. DocGo's proprietary ordering, dispatch and transportation management platform will coordinate all discharge transportation and all transportation vendors. Integrated with the health system's electronic health record, facility staff order transportation directly from the patient chart with patient demographics and insurance information automatically pulled from the patient record. DocGo's ordering platform also consolidates data from all transportation vendors into a single data warehouse, enabling unified reporting, enhanced analytics and actionable insights.
About DocGo
DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.
Forward-Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the Company's plans, strategies, outcomes, and prospects, both business and financial, including the Company's provision of services and further growth in New York. These statements are based on the beliefs and assumptions of the Company's management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words 'believes,' 'estimates,' 'expects,' 'projects,' 'forecasts,' 'may,' 'might,' 'will,' 'should,' 'could,' 'can,' 'would,' 'design,' 'potential,' 'seeks,' 'plans,' 'scheduled,' 'anticipates,' 'intends' or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company's control, and which may cause the Company's actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company's forward-looking statements, including, but not limited to the following: the Company's ability to successfully implement its business strategy, including with respect to the provision of services in New York; the Company's reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company's ability to compete effectively in a highly competitive industry; the Company's ability to maintain existing contracts, including the contract to provide services in New York; the Company's reliance on government contracts; the Company's ability to effectively manage its growth; the Company's financial performance and future prospects; the Company's ability to deliver on its business strategies or models, plans and goals; the Company's ability to expand geographically; the Company's competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company's filings with the Securities and Exchange Commission. The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
What economists are saying about inflation now
The hotter-than-expected July PPI print has some worried about how tariffs will impact inflation and what it ultimately means for the Federal Reserve and interest rates. Yahoo Finance Senior Reporter Allie Canal shares what some economists are saying about inflation now. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. Consumer sentiment fell for the first time since April last month as inflation expectations climbed. Anxiety around the impact of tariffs is weighing on the minds of consumers, but is inflation being driven by more than just tariffs? Yahoo Finance's Allie Canal live at the Nasdaq with more. Hi Allie. Hi Julie. And that's a question that's hard to say. Heading into this week, the focus was on core goods and the potential tariff impact on everything from apparel to furniture. But instead of a sharp jump in goods, we saw services inflation firm. That showed up in both the CPI and PPI reports earlier this week. The producer price index, uh, that surged to a three-year high signaling that businesses are absorbing much of the tariff burden. So the concern now is those higher costs could soon be passed on to consumers making the services side of the economy more expensive, just as the full tariff impact on goods is still set to play out. Now, markets may be mostly shrugging this off, still trading at those record highs, but economists are warning that the tariff effects haven't fully landed. Raymond James chief economist, Eugenio Aleman, he said in a note this week, quote, the full impact of tariffs is expected to materialize in next month's data, potentially pushing good prices higher. This complicates the Fed's September decision. And complicate is the key word here, Julie, especially after this morning's stable retail sales report. So this is really the chatter on Wall Street right now. And here's a bit more of what economists told us this week. more concerned about its impact on future CPI prints. I think it's telling you that the price effects are starting to work its way throughout the supply chain. Yeah, maybe maybe the July CPI print wasn't that strong, but come August, September, we might start to see firmer prints, and that puts the Fed in a tough spot. The good news here, as you say, is the tariff impulse into inflation wasn't as high as anticipated this month. The bad news, as you pointed out, is is that, um, services inflation was pretty soft in in prior months, and it did give the impression to many that, hey, maybe we could ignore tariff inflation because services weakness will offset it. But now I think a lot of that's reversed. These are broad-based inflationary pressures that we're seeing just now. I I I see more reason for rates to be rising in order to not let inflation, uh, get away from us. Inflation is the risk that's on our doorstep, much more so than the labor market. Uh, the Fed officials know that. And we do know that markets are still pricing in with near 100% certainty that the Fed cuts interest rates in September. Of course, Jackson Hole next week is going to give us a lot of clues into the thinking of the Fed with Federal Reserve chair, Jerome Powell, set to speak. But even with that September rate cut priced in by markets, you know, investors still think we are going to see an additional one to two rate cuts for from there to really end 2025 with about three cuts in total, and then more rate cuts are expected in 2026. So we're seeing that play out a bit in in the bond market. Long-term yields, like the 30-year yield, for example, is ticking higher today. But all of this, a big question mark is we continue to wade through this data with more prints and reports expected in the weeks and months ahead, Julie.
Yahoo
25 minutes ago
- Yahoo
5 Popular Stocks Still Worth Buying
When it comes to the stock market, the fastest growth usually comes from small companies, as they have room to run. It's a lot easier for a company worth $5 million to double in value than it is for one worth $1 trillion, for example. Check Out: Read Next: But just because a company is worth a certain dollar amount doesn't mean it's necessarily a good or a bad investment. Many well-known companies, for example, are up a lot in 2025 but are still highly recommended by analysts. Other popular companies have lagged the performance of the overall market in 2025 but still represent good buying opportunities. Here's a look at some big-time companies on both ends of the spectrum that might still be worth buying. Apple (AAPL) Price as of August 7, 2025: $220.03 YTD performance: -11.92% 12-month analyst price target: $233.11 Apple has been a market darling for years, but for the first half of 2025, the bloom came off the rose a bit. A combination of factors have created uncertainty for the company, which never translates to good results for a stock. Concerns over China, tariffs, sluggish artificial intelligence (AI) development and an overall unimpressive new product roster have weighed on the company. However, on July 31, Apple posted its biggest revenue growth since December 2021, putting the company back in the sights of analysts and investors alike, according to CNBC. For You: Amazon (AMZN) Price as of August 7, 2025: $223.13 YTD performance: 1.70% 12-month analyst price target: $261.03 The press has focused more on Amazon founder Jeff Bezos's extravagant Italian wedding than his company in 2025, but that may actually be creating an opportunity in the stock. As the largest online retailer in the world, Amazon benefits across multiple verticals as long as the economy remains strong. While, according to Forbes, concern over a potential recession and the effect of tariffs has held the stock back this year, discretionary spending has proven surprisingly resilient. Although the company might go through cycles, it's a long-term winner. Meta Platforms (META) Price as of August 7, 2025: $761.83 YTD performance: 30.33% 12-month analyst price target: $858.63 Meta Platforms has been on an absolute tear since Nov. 2022. After losing an incredible 64% that year, according to StatMuse, the stock has absolutely soared, gaining 188% in 2023, 67% in 2024 and over 27% YTD thus far in 2025. While those types of gains may scare off some investors, they're an indication of immense momentum and investors can't get enough. The company has been firing on all cylinders, tightening up cost controls, generating new and growing sources of revenue and focusing on AI, the buzzword of the 2020s. Analysts see continued success ahead for the company. Nvidia (NVDA) Price as of August 7, 2025: $180.77 YTD performance: 34.63% 12-month analyst price target: $183.38 Nvidia has been on a multi-decade run, making it one of the best performers in the whole stock market over the past 3-, 5-, 10- and 15-year periods. But analysts think there's no reason to get out now. In fact, some see the AI boom as throwing fuel on Nvidia's engines for years and years to come. The stock is notoriously volatile and got knocked down violently to the mid-90s in the April market selloff, losing more than one-third of its value. But since then, the stock has essentially doubled, showing the appetite investors have for this tech darling. *Victoria's Secret & Co. (VSCO) Price as of August 7, 2025: $21.63 YTD performance: -47.59% 12-month analyst price target: $21.60 Victoria's Secret gets an asterisk because while it is certainly a well-known company that hasn't performed well in 2025, it's also a much riskier option. Retail in general can be a tricky investment and specialty retail often goes through boom and bust cycles, the worst of which can send a company into bankruptcy. Analysts are decidedly tepid on the company's prospects for the next 12 months, but if you're a more aggressive investor, this is definitely a high-risk, high-reward type of stock. Caveats You should never buy any stock that doesn't match your investment objectives and risk tolerance. You should also never buy at stock based on a tip from a friend or a random article on the internet. Do your own research to find out what's really going on with a company's financials and future prospects and make your own decisions, perhaps in consultation with a financial advisor. Remember, even though the stocks on this list are by-and-large long-term winners, many now trade at lofty valuations and have appreciated sharply since the market's April lows. Invest for the long-term so you can recover from any short-term selloffs. Editor's note: Stock information was sourced from Yahoo! Finance and is current as of August 7, 2025. More From GOBankingRates 5 Ways Trump Signing the GENIUS Act Could Impact Retirees8 Common Mistakes Retirees Make With Their Social Security Checks This article originally appeared on 5 Popular Stocks Still Worth Buying
Yahoo
an hour ago
- Yahoo
Marlton Partners Files Preliminary Proxy Statement Related to Election of Directors for the 180 Degree Capital Board of Directors
CHICAGO, Aug. 15, 2025 /PRNewswire/ -- Marlton Partners L.P. (together with its affiliates and group members, "Marlton" or "we"), beneficial owners of approximately 5.8% of the outstanding stock of 180 Degree Capital Corp. (NASDAQ: TURN) ("TURN" or the "Company"), today announced that it has filed a preliminary proxy statement with the U.S. Securities Exchange and Commission to be used to solicit votes for the election of its four highly-qualified and independent director candidates – James C. Elbaor, Gabriel (Gabi) Gliksberg, Aaron Morris and Andrew (Andy) Greenberg (together, the "Nominees") - at the Company's upcoming Special Meeting of Shareholders scheduled for September 15. James C. Elbaor, Managing Member of Marlton, commented: "Yesterday, we filed our preliminary proxy related to our previously announced nomination of four highly-qualified director candidates to the TURN Board. As long-term shareholders, we remain committed to realizing TURN's full potential, and believe the September 15 meeting is a long overdue opportunity for Company shareholders to cast their vote on the composition of the Board. Since first engaging with the Company more than a year ago, we have remained steadfast in our intention of helping instill strong governance at TURN and to ensure that shareholder capital is respected. We look forward to TURN's owners having their rightful say on the future of the Company in September, and to speaking with shareholders directly about our nominees once we have a Definitive Proxy statement on file." About Marlton Partners Partners L.P. is a Chicago-based, privately held investment firm led by James C. Elbaor. The firm has a proven track record of success in investing in closed-end funds and acquires significant ownership positions in other assets where it believes long-term value can be enhanced through active ownership. Mr. Elbaor holds a B.A. from New York University and an M.B.A. from Columbia University. For more information about Marlton Partners L.P., please visit DISCLAIMERThis material does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in any state to any person. In addition, the discussions and opinions in this press release and the material contained herein are for general information only, and are not intended to provide investment advice. All statements contained in this press release that are not clearly historical in nature or that necessarily depend on future events are "forward-looking statements," which are not guarantees of future performance or results, and the words "may," "might," "could," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms and other comparable terminology are generally intended to identify forward-looking statements. Any such forward-looking statements contained herein are based on current assumptions, estimates and expectations, but are subject to a number of known and unknown risks and significant business, economic and competitive uncertainties that may cause actual results to differ materially from expectations. Any forward-looking statements should be considered in light of those risk factors. The Participants (as defined below) caution readers not to rely on any such forward-looking statements, which speak only as of the date they are made. Certain information included in this press release is based on data obtained from sources considered to be reliable. No representation is made with respect to the accuracy or completeness of such data, and any analyses provided to assist the recipient of this press release in evaluating the matters described herein may be based on subjective assessments and assumptions and may use one among alternative methodologies that produce different results. Accordingly, any analyses should also not be viewed as factual and should not be relied upon as an accurate prediction of future results. Any figures are unaudited estimates and subject to revision without notice. The Participants disclaim any intent or obligation to publicly update or revise any such forward-looking statements to reflect any change in expectations or future events, conditions or circumstances on which any such forward-looking statements may be based, or that may affect the likelihood that actual results may differ from those set forth in such forward-looking statements. CERTAIN INFORMATION CONCERNING THE PARTICIPANTS Marlton Partners L.P., a Delaware limited partnership ("Marlton Partners"), together with the other Participants named herein, filed a preliminary proxy statement and an accompanying proxy card with the Securities and Exchange Commission ("SEC") on August 15, 2025 to be used to solicit votes for the election of its slate of highly-qualified director nominees at the special meeting of shareholders of 180 Degree Capital Corporation, a New York corporation (the "Company"), to be held on September 15, 2025, for the sole purpose of the election of directors. THE PARTICIPANTS STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS, INCLUDING A PROXY CARD, AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR. The participants in the proxy solicitation are expected to be Marlton Partners, Marlton, LLC, James C. Elbaor, Aaron T. Morris, Gabriel D. Gliksberg, ATG Fund II, LLC, ATG Capital Management, LLC, and Andrew M. Greenberg (collectively, the "Participants"). As of the date hereof, Marlton Partners is the beneficial owner of 174,867 shares of common stock, par value $0.03, of the Company (the "Common Shares"). Marlton, LLC, a Delaware limited liability company ("Marlton") is the investment manager of Marlton Partners and, by virtue of that relationship, may be deemed to beneficially own the 174,867 Common Shares beneficially owned by Marlton Partners. Mr. Elbaor is the President of Marlton and, by virtue of that relationship, may be deemed to beneficially own the 174,867 Common Shares beneficially owned directly by Marlton. ATG Fund II LLC, a Delaware limited liability company ("ATG Fund II") is the beneficial owner of 300,004 Common Shares. ATG Capital Management, LLC, a Delaware limited liability company ("ATG Management"), is the managing member of ATG Fund II and, by virtue of that relationship, may be deemed to beneficially own the 300,004 Common Shares beneficially owned by ATG Fund II. Mr. Gliksberg is the managing member of ATG Management and, by virtue of that relationship, may be deemed to beneficially own the 300,004 Common Shares beneficially owned by ATG Management. As of the date hereof, Mr. Gliksberg is the beneficial owner of 87,862 Common Shares. As of the date hereof, Mr. Morris is the beneficial owner of 10,670 Common Shares. As of the date hereof, Mr. Greenberg is the beneficial owner of 10,000 Common Shares. As of the date hereof, the Participants may be deemed to collectively beneficially own 583,403 Common Shares. Media Contact:ASC AdvisorsTaylor Ingraham (203 992 1230)tingraham@ Investors Contact:James C. Elbaor (214-405-4141)James@ View original content: SOURCE Marlton Partners L.P. Sign in to access your portfolio
